» Articles » PMID: 34559005

Assisted Versus Manual Interpretation of Low-Dose CT Scans for Lung Cancer Screening: Impact on Lung-RADS Agreement

Abstract

Purpose To compare the inter- and intraobserver agreement and reading times achieved when assigning Lung Imaging Reporting and Data System (Lung-RADS) categories to baseline and follow-up lung cancer screening studies by using a dedicated CT lung screening viewer with integrated nodule detection and volumetric support with those achieved by using a standard picture archiving and communication system (PACS)-like viewer. Materials and Methods Data were obtained from the National Lung Screening Trial (NLST). By using data recorded by NLST radiologists, scans were assigned to Lung-RADS categories. For each Lung-RADS category (1 or 2, 3, 4A, and 4B), 40 CT scans (20 baseline scans and 20 follow-up scans) were randomly selected for 160 participants (median age, 61 years; interquartile range, 58-66 years; 61 women) in total. Seven blinded observers independently read all CT scans twice in a randomized order with a 2-week washout period: once by using the standard PACS-like viewer and once by using the dedicated viewer. Observers were asked to assign a Lung-RADS category to each scan and indicate the risk-dominant nodule. Inter- and intraobserver agreement was analyzed by using Fleiss κ values and Cohen weighted κ values, respectively. Reading times were compared by using a Wilcoxon signed rank test. Results The interobserver agreement was moderate for the standard viewer and substantial for the dedicated viewer, with Fleiss κ values of 0.58 (95% CI: 0.55, 0.60) and 0.66 (95% CI: 0.64, 0.68), respectively. The intraobserver agreement was substantial, with a mean Cohen weighted κ value of 0.67. The median reading time was significantly reduced from 160 seconds with the standard viewer to 86 seconds with the dedicated viewer ( < .001). Conclusion Lung-RADS interobserver agreement increased from moderate to substantial when using the dedicated CT lung screening viewer. The median reading time was substantially reduced when scans were read by using the dedicated CT lung screening viewer. CT, Thorax, Lung, Computer Applications-Detection/Diagnosis, Observer Performance, Technology Assessment © RSNA, 2021.

Citing Articles

Artificial Intelligence-Empowered Radiology-Current Status and Critical Review.

Obuchowicz R, Lasek J, Wodzinski M, Piorkowski A, Strzelecki M, Nurzynska K Diagnostics (Basel). 2025; 15(3).

PMID: 39941212 PMC: 11816879. DOI: 10.3390/diagnostics15030282.


Software using artificial intelligence for nodule and cancer detection in CT lung cancer screening: systematic review of test accuracy studies.

Geppert J, Asgharzadeh A, Brown A, Stinton C, Helm E, Jayakody S Thorax. 2024; 79(11):1040-1049.

PMID: 39322406 PMC: 11503082. DOI: 10.1136/thorax-2024-221662.


Errors in Radiology: A Standard Review.

Pesapane F, Gnocchi G, Quarrella C, Sorce A, Nicosia L, Mariano L J Clin Med. 2024; 13(15).

PMID: 39124573 PMC: 11312890. DOI: 10.3390/jcm13154306.


Application of computer-aided detection for NCCN-based follow-up recommendation in subsolid nodules: Effect on inter-observer agreement.

Quanyang W, Lina Z, Yao H, Jiawei W, Wei T, Linlin Q Cancer Med. 2024; 13(2):e6967.

PMID: 38348960 PMC: 10832308. DOI: 10.1002/cam4.6967.


Pricing and cost-saving potential for deep-learning computer-aided lung nodule detection software in CT lung cancer screening.

Du Y, Greuter M, Prokop M, de Bock G Insights Imaging. 2023; 14(1):208.

PMID: 38010436 PMC: 10682324. DOI: 10.1186/s13244-023-01561-z.


References
1.
Lee J, Lim J, Kim Y, Kim H, Goo J, Lee C . Development of Protocol for Korean Lung Cancer Screening Project (K-LUCAS) to Evaluate Effectiveness and Feasibility to Implement National Cancer Screening Program. Cancer Res Treat. 2019; 51(4):1285-1294. PMC: 6790831. DOI: 10.4143/crt.2018.464. View

2.
Tammemagi M, Ritchie A, Atkar-Khattra S, Dougherty B, Sanghera C, Mayo J . Predicting Malignancy Risk of Screen-Detected Lung Nodules-Mean Diameter or Volume. J Thorac Oncol. 2018; 14(2):203-211. DOI: 10.1016/j.jtho.2018.10.006. View

3.
Pastorino U, Silva M, Sestini S, Sabia F, Boeri M, Cantarutti A . Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy. Ann Oncol. 2019; 30(10):1672. PMC: 6857602. DOI: 10.1093/annonc/mdz169. View

4.
Benzaquen J, Boutros J, Marquette C, Delingette H, Hofman P . Lung Cancer Screening, Towards a Multidimensional Approach: Why and How?. Cancers (Basel). 2019; 11(2). PMC: 6406662. DOI: 10.3390/cancers11020212. View

5.
de Koning H, van der Aalst C, de Jong P, Scholten E, Nackaerts K, Heuvelmans M . Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial. N Engl J Med. 2020; 382(6):503-513. DOI: 10.1056/NEJMoa1911793. View